Diabetes Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Diabetes stocks.

Diabetes Stocks Recent News

Date Stock Title
Apr 26 NVO Dow Jones Futures: Nvidia Leads 7 New Buys As Market Roars; Fed, Apple, Super Micro Loom
Apr 26 NVO Novo Nordisk: Medicare Coverage To Unlock Another Big Market For Wegovy
Apr 26 NVO Stocks to watch next week: Amazon, Apple, Anglo American and Novo Nordisk
Apr 26 NVO Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
Apr 26 MRK Investor Sentiment Improves Slightly, But Dow Tumbles Over 350 Points
Apr 25 NVO Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
Apr 25 MRK Merck (MRK) Q1 2024 Earnings Call Transcript
Apr 25 MRK Merck Stock Gains On Its Blockbuster Cancer Drug Keytruda, Raises Annual Outlook
Apr 25 MRK Merck & Co., Inc. (MRK) Q1 2024 Earnings Call Transcript
Apr 25 MRK Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Apr 25 MRK Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
Apr 25 MRK 20 Fastest Growing Health Tech Companies in the World
Apr 25 MRK Merck raises 2024 guidance on cancer drug demand
Apr 25 MRK Meta Falls 15% On Great Earnings, Tesla Rises 12% On Ugly Earnings – Here Is The Real Reason
Apr 25 TNDM Earnings Preview: Tandem Diabetes Care, Inc. (TNDM) Q1 Earnings Expected to Decline
Apr 25 MRK Merck Stock Climbs After Higher-Than-Expected Sales of Cancer Drug Keytruda
Apr 25 NVO Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Apr 25 XOMA XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)
Apr 25 MRK Merck raises guidance as Keytruda sales jump 20% in Q1
Apr 25 MRK UPDATE 3-Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda
Diabetes

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags